222 related articles for article (PubMed ID: 16675323)
1. Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids.
Kelly MM; Leigh R; Jayaram L; Goldsmith CH; Parameswaran K; Hargreave FE
J Allergy Clin Immunol; 2006 May; 117(5):989-94. PubMed ID: 16675323
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
[TBL] [Abstract][Full Text] [Related]
3. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
Boulet LP; Turcotte H; Prince P; Lemière C; Olivenstein R; Laprise C; Larivée P; Bégin P; Laviolette M
Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
[TBL] [Abstract][Full Text] [Related]
4. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.
Smith AD; Cowan JO; Brassett KP; Herbison GP; Taylor DR
N Engl J Med; 2005 May; 352(21):2163-73. PubMed ID: 15914548
[TBL] [Abstract][Full Text] [Related]
5. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
Ohbayashi H
Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
[TBL] [Abstract][Full Text] [Related]
6. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough.
Chaudhuri R; McMahon AD; Thomson LJ; MacLeod KJ; McSharry CP; Livingston E; McKay A; Thomson NC
J Allergy Clin Immunol; 2004 Jun; 113(6):1063-70. PubMed ID: 15208586
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics.
Kawayama T; Kinoshita T; Imaoka H; Gauvreau GM; O'Byrne PM; Aizawa H
Respirology; 2008 Nov; 13(7):1000-1007. PubMed ID: 18699801
[TBL] [Abstract][Full Text] [Related]
8. Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization.
Di Franco A; Bacci E; Bartoli ML; Cianchetti S; Dente FL; Taccola M; Vagaggini B; Zingoni M; Paggiaro PL
Pulm Pharmacol Ther; 2006; 19(5):353-60. PubMed ID: 16289980
[TBL] [Abstract][Full Text] [Related]
9. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation.
Berlyne GS; Parameswaran K; Kamada D; Efthimiadis A; Hargreave FE
J Allergy Clin Immunol; 2000 Oct; 106(4):638-44. PubMed ID: 11031333
[TBL] [Abstract][Full Text] [Related]
10. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate.
Gyllfors P; Dahlén SE; Kumlin M; Larsson K; Dahlén B
J Allergy Clin Immunol; 2006 Jul; 118(1):78-83. PubMed ID: 16815141
[TBL] [Abstract][Full Text] [Related]
11. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
Vignola AM; Riccobono L; Profita M; Foresi A; Di Giorgi R; Guerrera D; Gjomarkaj M; Di Blasi P; Paggiaro PL
Allergy; 2005 Dec; 60(12):1511-7. PubMed ID: 16266383
[TBL] [Abstract][Full Text] [Related]
12. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
[TBL] [Abstract][Full Text] [Related]
13. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation.
Loppow D; Schleiss MB; Kanniess F; Taube C; Jörres RA; Magnussen H
Respir Med; 2001 Feb; 95(2):115-21. PubMed ID: 11217907
[TBL] [Abstract][Full Text] [Related]
14. Blunting airway eosinophilic inflammation results in a decreased airway neutrophil response to inhaled LPS in patients with atopic asthma: a role for CD14.
Alexis NE; Peden DB
J Allergy Clin Immunol; 2001 Oct; 108(4):577-80. PubMed ID: 11590384
[TBL] [Abstract][Full Text] [Related]
15. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids.
Deykin A; Lazarus SC; Fahy JV; Wechsler ME; Boushey HA; Chinchilli VM; Craig TJ; Dimango E; Kraft M; Leone F; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
J Allergy Clin Immunol; 2005 Apr; 115(4):720-7. PubMed ID: 15805990
[TBL] [Abstract][Full Text] [Related]
16. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
Ravensberg AJ; Luijk B; Westers P; Hiemstra PS; Sterk PJ; Lammers JW; Rabe KF
Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
[TBL] [Abstract][Full Text] [Related]
17. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
[TBL] [Abstract][Full Text] [Related]
18. Effects of steroid therapy on inflammatory cell subtypes in asthma.
Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343
[TBL] [Abstract][Full Text] [Related]
19. Effect of obesity on airway inflammation: a cross-sectional analysis of body mass index and sputum cell counts.
Todd DC; Armstrong S; D'Silva L; Allen CJ; Hargreave FE; Parameswaran K
Clin Exp Allergy; 2007 Jul; 37(7):1049-54. PubMed ID: 17581198
[TBL] [Abstract][Full Text] [Related]
20. Effect of fluticasone on markers of inflammation and quality of life in steroid-naive patients with mild asthma.
Ehrs PO; Sundblad BM; Larsson K
Clin Respir J; 2010 Jan; 4(1):51-8. PubMed ID: 20298418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
